EMA Recommends Granting Market Authorization in EU for New Medicine for Rare Type of Eye Cancer February 28, 2022 Auto Bot News 0 EMA has recommended granting a marketing authorization in the EU for Kimmtrak (tebentafusp), a new medicine for a rare type of eye cancer.
